GlassScriptPhysician profile
Graham C Chapman
NPI 1225473101
$4,563.04
in general payments reported to CMS, 2019-2025
16 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $905 · 2021: $164 · 2022: $871 · 2023: $112 · 2024: $1,436 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $804.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,057.96 | 2024 | |
| Boston Scientific Corporation | $1,004.49 | 2019-2025 | Resolution 360 Clip, Bulkamid |
| Medtronic USA, INC. | $605.89 | 2019-2020 | |
| Northgate Technologies, INC. | $600.00 | 2022 | |
| Axonics, INC. | $276.91 | 2020 | |
| Genentech USA, INC. | $239.84 | 2024-2025 | Vabysmo, Itovebi |
| Medtronic, INC. | $179.61 | 2021-2022 | |
| Astellas Pharma US INC | $135.75 | 2019 | |
| Myriad Genetic Laboratories, INC. | $125.50 | 2025 | Myrisk |
| Allergan, INC. | $114.14 | 2019 | |
| Ethicon US, LLC | $96.60 | 2024 | Echelon; Endopath |
| Conmed Corporation | $38.36 | 2022-2023 | Airseal |
| Astrazeneca Pharmaceuticals LP | $33.63 | 2024 | Lynparza |
| Pfizer INC. | $23.57 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.19 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.60 | 2024 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Graham Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.